Literature DB >> 11379354

Evaluation of gastroenteric bypass for unresectable pancreatic cancer.

Y Fujino1, Y Suzuki, T Kamigaki, M Mitsutsuji, Y Kuroda.   

Abstract

BACKGROUND/AIMS: It is controversial as to whether gastroenteric bypass is helpful for patients with unresectable pancreatic cancer. This study was designed to evaluate the effects of gastroenteric bypass on dietary intake and the symptoms of gastric outlet obstruction in these patients.
METHODOLOGY: We reviewed the cases of 101 patients with unresectable pancreatic cancer surgically treated at the Kobe University Hospital. The effects of gastroenteric bypass were examined by comparing the dietary intake and the symptoms of gastric outlet obstruction on admission, 1 month and 3 months after the operation.
RESULTS: The analyses of dietary intake and the symptoms indicated that the gastroenteric bypass operation was not helpful for most of the patients with unresectable pancreatic cancer. Multivariate logistic regression model revealed that dietary intake on admission was the strongest parameter for dietary intake at one month after operation. The patients with a low dietary intake on admission often required a nasogastric tube after the bypass operation, reflecting progression of the disease.
CONCLUSIONS: Gastroenteric bypass had no advantage to improve dietary intake and symptoms for almost all the patients with unresectable pancreatic cancer. It was effective only for patients with a high dietary intake without symptoms of gastric outlet obstruction on admission.

Entities:  

Mesh:

Year:  2001        PMID: 11379354

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

1.  Palliative pancreatectomy with postoperative gemcitabine for patients with advanced pancreatic cancer.

Authors:  Yasuhiro Fujino; Tetsuya Sakai; Yoshikazu Kuroda
Journal:  J Gastroenterol       Date:  2008-03-29       Impact factor: 7.527

2.  Predictors of the patency of self-expandable metallic stents in malignant gastroduodenal obstruction.

Authors:  Seung Han Kim; Hoon Jai Chun; In Kyung Yoo; Jae Min Lee; Seung Joo Nam; Hyuk Soon Choi; Eun Sun Kim; Bora Keum; Yeon Seok Seo; Yoon Tae Jeen; Hong Sik Lee; Soon Ho Um; Chang Duck Kim
Journal:  World J Gastroenterol       Date:  2015-08-14       Impact factor: 5.742

3.  Self-expandable metallic stent placement in the palliative treatment of malignant obstruction of gastric outlet and duodenum.

Authors:  Erkan Caglar; Ahmet Dobrucali
Journal:  Clin Endosc       Date:  2013-01-31

4.  A patient with unresectable advanced pancreatic cancer achieving long-term survival with gemcitabine chemotherapy.

Authors:  Yoshiki Okamoto; Takashi Maeba; Keitarou Kakinoki; Keiichi Okano; Kunihiko Izuishi; Hisao Wakabayashi; Hisashi Usuki; Yasuyuki Suzuki
Journal:  World J Gastroenterol       Date:  2008-11-28       Impact factor: 5.742

5.  Risk factors for morbidity and mortality following gastroenterostomy.

Authors:  Martin Poulsen; Mauro Trezza; Ghayyath H Atimash; Lars T Sorensen; Finn Kallehave; Ulla Hemmingsen; Lars N Jorgensen
Journal:  J Gastrointest Surg       Date:  2009-04-28       Impact factor: 3.452

6.  [Endoscopic palliation of malignant gastric outlet obstruction by self-expanding metal stents].

Authors:  Azab el-Shabrawi; Herwig Cerwenka; Heinz Bacher; Josef Schweiger; Peter Kornprat; Hans-Jörg Mischinger
Journal:  Wien Klin Wochenschr       Date:  2003-12-15       Impact factor: 1.704

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.